A Preview Of Ocular Therapeutix's Earnings
Portfolio Pulse from Benzinga Insights
Ocular Therapeutix (NASDAQ:OCUL) is set to release its latest quarterly earnings report on Monday, 2023-08-07. Analysts estimate an earnings per share (EPS) of $-0.29. The company's past performance shows a pattern of EPS misses followed by share price increases. The stock is currently trading at $4.41, down 11.56% over the last 52-week period.
August 04, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Ocular Therapeutix is expected to report an EPS of $-0.29. Despite past EPS misses, the stock price often increases. The stock is currently down 11.56% over the last 52 weeks.
The company's earnings report is a key event that could impact its stock price. Despite past EPS misses, the stock price often increases, suggesting that investors may be focusing more on other aspects of the company's performance. However, the stock is currently down over the past year, indicating a bearish sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100